| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | -5.18% | +0.58% | -5.76% | -5.76% | — |
| 14d | 1 | +100.00% | -9.48% | -0.60% | -8.88% | -8.88% | — |
| 30d | 1 | +100.00% | -19.48% | -3.75% | -15.73% | -15.73% | — |
| 60d | 1 | +0.00% | +1.44% | +4.62% | -3.19% | -3.19% | — |
| 90d | 1 | +100.00% | -3.59% | — | — | — | — |
| 180d | 1(1 pending) | — | — | — | — | — | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 5,407 | $13.41 | $72.5K | 66,019 | Jun 30, 2026 | Jul 1, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE Chief Medical Officer | 5,407 | — | — | 81,093 | Jun 30, 2026 | Jul 1, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,407 | $24.50 | $132.5K | 60,612 | Jun 30, 2026 | Jul 1, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE Chief Medical Officer | 6,000 | — | — | 60,000 | Jun 29, 2026 | Jun 30, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 6,000 | $22.95 | $137.7K | 59,992 | Jun 29, 2026 | Jun 30, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 6,000 | $7.56 | $45.4K | 65,992 | Jun 29, 2026 | Jun 30, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 30,000 | $7.56 | $226.8K | 89,992 | Jun 24, 2026 | Jun 25, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 30,000 | $21.42 | $642.7K | 59,992 | Jun 24, 2026 | Jun 25, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE Chief Medical Officer | 30,000 | — | — | 66,000 | Jun 24, 2026 | Jun 25, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE Chief Medical Officer | 6,000 | — | — | 96,000 | Jun 23, 2026 | Jun 25, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 11,845 | $20.22 | $239.5K | 59,992 | Jun 23, 2026 | Jun 25, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 6,000 | $7.56 | $45.4K | 71,837 | Jun 23, 2026 | Jun 25, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE Chief Medical Officer | 9,189 | $19.50 | $179.2K | 65,837 | Feb 23, 2026 | Feb 24, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | SALE Chief Medical Officer | 3,155 | $15.17 | $47.9K | 75,026 | Jan 5, 2026 | Jan 5, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 31,000 | — | — | 78,181 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 139,000 | — | — | 139,000 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 36,000 | — | — | 45,189 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 161,000 | — | — | 161,000 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 30,000 | Sep 13, 2024 | Sep 13, 2024 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 121,000 | — | — | 121,000 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 135,000 | — | — | 135,000 | Jan 3, 2023 | Jan 4, 2023 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 36,000 | — | — | 36,000 | Dec 15, 2022 | Dec 19, 2022 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 36,000 | — | — | 36,000 | Oct 31, 2022 | Nov 1, 2022 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 86,500 | — | — | 86,500 | Mar 1, 2022 | Mar 2, 2022 ↗ | View → |
| GLUE MONTE ROSA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 387,069 | — | — | 387,069 | Jun 23, 2021 | Jun 25, 2021 ↗ | View → |